Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cortes

Showing results (171-180 of 584) with videos related to

Pageof 59
Sort By:
Nutricion Hospitalaria|October 29, 2013
Maternal age as risk factor of prematurity in Spain; Mediterranean areaE Cortes Castell, M M Rizo-Baeza, M J Aguilar Cordero, et al.
Human Pathology|September 4, 2012
Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemiaDaniela Hoehn, L Jeffrey Medeiros, Hagop M Kantarjian, et al.
Gynecologic Oncology|January 1, 2024
The interaction between social determinants of health and cervical cancer survival: A systematic reviewKellen Cristine Tjioe, Marisol Miranda-Galvis, Marian Symmes Johnson, et al.
Acta Odontologica Latinoamericana : AOL|October 21, 2009
In vitro lethal photosensitization of S. mutans using methylene blue and toluidine blue O as photosensitizersPatrícia V Araújo, Karina I R Teixeira, Lincoln D Lanza, et al.
Leukemia Research|May 28, 2015
Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcomeLucia Masarova, Kate J Newberry, Sherry A Pierce, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Journal of Medical Economics|July 11, 2023
Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinibJorge E Cortes, Delphine Rea, Michael J Mauro, et al.
Investigative Ophthalmology & Visual Science|July 26, 2016
In Vivo Imaging of Corneal Endothelial Dystrophy in Boston Terriers: A Spontaneous, Canine Model for Fuchs' Endothelial Corneal DystrophySara M Thomasy, Dennis E Cortes, Alyssa L Hoehn, et al.
Leukemia Research|August 10, 2016
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patientsDavid J Dorer, Ronald K Knickerbocker, Michele Baccarani, et al.
Veterinary Parasitology|July 11, 2006
Immunodiagnosis of Besnoitia besnoiti infection by ELISA and Western blotH C E Cortes, S Nunes, Y Reis, et al.
Pageof 59

Showing results (171-180 of 584) with videos related to

Sort By:
Pageof 59
Nutricion Hospitalaria|October 29, 2013
Maternal age as risk factor of prematurity in Spain; Mediterranean areaE Cortes Castell, M M Rizo-Baeza, M J Aguilar Cordero, et al.
Human Pathology|September 4, 2012
Digital image analysis as a tool to assess the effects of imatinib on trabecular bone in patients with chronic myelogenous leukemiaDaniela Hoehn, L Jeffrey Medeiros, Hagop M Kantarjian, et al.
Gynecologic Oncology|January 1, 2024
The interaction between social determinants of health and cervical cancer survival: A systematic reviewKellen Cristine Tjioe, Marisol Miranda-Galvis, Marian Symmes Johnson, et al.
Acta Odontologica Latinoamericana : AOL|October 21, 2009
In vitro lethal photosensitization of S. mutans using methylene blue and toluidine blue O as photosensitizersPatrícia V Araújo, Karina I R Teixeira, Lincoln D Lanza, et al.
Leukemia Research|May 28, 2015
Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcomeLucia Masarova, Kate J Newberry, Sherry A Pierce, et al.
Cancer|January 15, 1995
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up resultsJ E Cortes, M Talpaz, M Beran, et al.
Journal of Medical Economics|July 11, 2023
Health care resource utilization in 3L + patients with chronic phase chronic myeloid leukemia receiving asciminib or bosutinibJorge E Cortes, Delphine Rea, Michael J Mauro, et al.
Investigative Ophthalmology & Visual Science|July 26, 2016
In Vivo Imaging of Corneal Endothelial Dystrophy in Boston Terriers: A Spontaneous, Canine Model for Fuchs' Endothelial Corneal DystrophySara M Thomasy, Dennis E Cortes, Alyssa L Hoehn, et al.
Leukemia Research|August 10, 2016
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patientsDavid J Dorer, Ronald K Knickerbocker, Michele Baccarani, et al.
Veterinary Parasitology|July 11, 2006
Immunodiagnosis of Besnoitia besnoiti infection by ELISA and Western blotH C E Cortes, S Nunes, Y Reis, et al.
Pageof 59